Compare AVDL & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVDL | SEDG |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | Ireland | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1996 | 2015 |
| Metric | AVDL | SEDG |
|---|---|---|
| Price | $21.69 | $35.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 20 |
| Target Price | $19.14 | ★ $26.86 |
| AVG Volume (30 Days) | 1.6M | ★ 2.8M |
| Earning Date | 03-02-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $248,517,000.00 | ★ $1,045,303,000.00 |
| Revenue This Year | $65.47 | $33.45 |
| Revenue Next Year | $30.88 | $15.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.88 | 2.35 |
| 52 Week Low | $6.38 | $11.00 |
| 52 Week High | $23.57 | $48.60 |
| Indicator | AVDL | SEDG |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 57.72 |
| Support Level | $21.52 | $32.02 |
| Resistance Level | $21.69 | $37.37 |
| Average True Range (ATR) | 0.06 | 2.33 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 66.67 | 79.72 |
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.